Beaten-down biotech stocks could be set for a turnaround after Election Day, according to one strategist.
The Nasdaq Biotech ETF, the
"The big event, clearly, for the biotech space right now is the election," Gilbert said Friday on CNBC's "
She noted that if Democratic nominee Hillary Clinton were to win the election and the Democrats were to sweep the House, it could be bad for the biotech space. However, with the likelihood of an all-Democratic house slim, she does expect to see a 3 to 5 percent rally for the group of stocks in...